Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Health Status After Switching Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers to Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania: An Interventional Study

NCT06704633 is registered in ClinicalTrials.gov with Martin Rohacek as lead sponsor.

NCT NCT06704633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06704633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Health Status After Switching Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers to Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania: An Interventional Study
Lead sponsor
Martin Rohacek
Phase
Phase 4
Overall status
Recruiting
Start date
June 30, 2026
Completion date
November 30, 2028
Enrollment
298 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure